Skip to main content

NRXP

NRX Pharmaceuticals, Inc.

Company with tickers: NRXP, NRXPW

CIK
1719406
CUSIP
629444209
Shares Outstanding
41,943,278
13F Activity (30d)
27 filings 25 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 34
Total Value: $13,687,073
Total Shares: 6,425,864

Institutional Ownership Trend

8 quarters

Holder Concentration

Across 34 13F filers · Δ vs Dec 31, 2025
Top Holder
46.7%
Jun 2024 → Mar 2026 · range 29.0% – 57.1%
−10.4 pts
Top 5
82.3%
Jun 2024 → Mar 2026 · range 81.1% – 89.8%
−5.7 pts
Top 10
92.7%
Jun 2024 → Mar 2026 · range 92.7% – 97.8%
−2.7 pts
HHI
2,639
Jun 2024 → Mar 2026 · range 1,775 – 3,566
Highly concentrated −927

Quarterly Activity

vs Dec 31, 2025
New
11
Increased
13
Decreased
2
Sold Out
7
Unchanged
8
Holder count: +4
Institutional value: -5.2%
Shares held: +20.6%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 38 of 38
Export CSV
Holder Value (USD) % of 13F Shares Open